In order to determine new prognostic factors in these kinds of tumours we analysed the relationship between relapse-free survival (RFS) and molecular factors including MSI status, hMLH-1/hMSH-2 expression, EGFR catalytic domain mutations and EGFR expression. This evidence concerns the gene EGFR and neoplasm.